2.37 USD
▲+0.02+4.87%
盘后 2.33 +3.10%
2026-08-03
市值
$38.04M
市盈率
—
EPS
-0.77
股息率
—
52 周区间
2.05 – 7.33
成交量
256.69K
Beta
-1.20
目标价
24.50
52W 低 2.0552W 高 7.33
价格走势
公司简介
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly pat...